Abstract:Objective To analyze the clinical and neuroimaging characteristics and prognosis of patients with hepatic myelopathy and hepatic encephalopathy. Methods Clinical data of 13 cases with hepatic myelopathy and hepatic encephalopathy were retrospectively reviewed. Results All patients had chronic liver disease and 11 developed extensive porto-systemic shunting due to surgical porto-caval shunting or spontaneous shunting through collateral vessels. The major clinical characteristics were reversible encephalopathy symptoms,disabling progressive spastic paraparesis (most in the legs,only one with quadriplegia),no sphincter involvements except the patient with quadriplegia,and no sensory disturbances. The blood ammonia level increased in 9 patients. T1 weighted cranial MR imaging in 8 cases showed bilateral basal ganglia high signal intensity. MRI of the spine did not reveal any abnormal findings except 2 cases. Electroencephalogram (EEG) of 8 patients showed diffuse θ waves,2 of whom had triphasic wave. Therapy protocol included protein restriction,branched-chain amino acid,acetylglutamide,oral neomycin,lactulose,neurotrophy and colonic exclusion,3 with glucocorticoid. One patient experienced improved neurological symptoms after liver transplantation,whereas three patients died and the other patients who only received medical treatments gained partial improvements of encephalopathy symptoms but not prevent the progression of spastic paraparesis. Conclusion Hepatic myelopathy was not parallel with hepatic encephalopathy. The pathophysiology may be different between hepatic myelopathy and hepatic encephalopathy. Neuroimaging techniques cast new lights on the diagnosis of neurological syndromes in patients with liver failure. Those medical treatments decreased the numbers of encephalopathic episodes but can not improve the poor prognosis of spastic paraparesis. Liver transplantation may be a promising method to improve the neurological syndromes of liver failure.

Chronic Heroin Toxic Encephalopathy

Clinical and Neuroimaging Characteristics and Prognosis of Patients with Hepatic Myelopathy and Hepatic Encephalopathy

[Clinical and neuroimaging features of heroin spongiform leukoencephalopathy]

Toxic Encephalopathy Caused By Occupational Exposure To 1, 2-Dichloroethane

Clinical and Cranial MRI Analysis on Five Cases of Toxic Encephalopathy Induced by Dichloroethane

Reversible Brain White Matter Microstructure Changes in Heroin Addicts: A Longitudinal Study

Heroin-Induced Leukoencephalopathy: A Case Report

COMPARATIVE STUDY ON BRAIN COMPUTERIZED TOMOGRAPHY OF HEROIN DEPENDENT PATIENTS

5 cases analysis of toxic encephalopathy induced by organic solvents

Brain Function of Heroin Addicts after Withdrawal.

1HMR Spectrosocopy and Diffusion Tensor Technology in Heroin-Induced Brain Damage

Methamphetamine-induced Toxic Leukoencephalopathy: Clinical, Radiological and Autopsy Findings

[Neurologic complications in heroin abuse. Illustrated by two unusual cases]

Changes in Brain Gray Matter in Abstinent Heroin Addicts.

Gray Matter Alteration in Heroin-Dependent Men: an Atlas-Based Magnetic Resonance Imaging Study.

White Matter Impairment in Chronic Heroin Dependence: A Quantitative Dti Study

Voxel Based Morphometry Study of Cerebral Gray Matter Volume in Patients with Heroin Dependence

Imaging Features of Toxic Encephalopathy and the Values of DWI

Clinical analysis and treatment of Hashimoto's encephalopathy and encephalomyelopathy

A study of 1 H-MRspectroscopy in the prefrontal cortex and amygdala of heroine abusers

Single Photon Emission Computerized Tomography of Spongiform Leukoencephalopathy Heroin Addicts: Analysis of 10 Cases.